Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Saylor · SciRah

Researcher profile · Semantic Scholar

P. Saylor

Share profile

P. Saylor — researcher profile on SciRah

h-index: 30
Works: 129
Citations: 4,186

Most-cited papers

Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
N. Giacalone, W. Shipley, R. Clayman, A. Niemierko +10 more
2017European Urology349 citations
Semantic Scholar
Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
T. Gilligan, D. Lin, R. Aggarwal, D. Chism +26 more
2019The Journal of the National Comprehensive Cancer Network312 citations Open access
Semantic Scholar
Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses
Taghreed Hirz, S. Mei, Hirak Sarkar, Y. Kfoury +16 more
2023Nature Communications274 citations Open access
Semantic Scholar
Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment
Y. Kfoury, N. Baryawno, N. Sévère, S. Mei +14 more
2020bioRxiv261 citations
Semantic Scholar
Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance).
M. Smith, S. Halabi, C. Ryan, A. Hussain +11 more
2014Journal of Clinical Oncology233 citations Open access
Semantic Scholar
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis.
A. Zlotta, L. Ballas, A. Niemierko, K. Lajkosz +25 more
2023The Lancet Oncology208 citations
Semantic Scholar
Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal Validation.
A. Karhade, Q. Thio, P. Ogink, C. Bono +7 more
2019Neurosurgery176 citations Open access
Semantic Scholar
Development of Machine Learning Algorithms for Prediction of 30-Day Mortality After Surgery for Spinal Metastasis.
A. Karhade, Q. Thio, P. Ogink, Akash A. Shah +7 more
2018Neurosurgery144 citations Open access
Semantic Scholar
Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial.
J. Coen, Peixin Zhang, P. Saylor, Cheryl T. Lee +11 more
2019Journal of Clinical Oncology121 citations Open access
Semantic Scholar
Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA
Pedro C. Barata, N. Agarwal, R. Nussenzveig, Benjamin Gerendash +12 more
2020Journal for ImmunoTherapy of Cancer112 citations Open access
Semantic Scholar
A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases
Richard J. Lee, P. Saylor, M. D. Michaelson, S. Rothenberg +8 more
2013Clinical Cancer Research86 citations Open access
Semantic Scholar
Sacituzumab govitecan (IMMU-132) in patients with previously treated metastatic urothelial cancer (mUC): Results from a phase I/II study.
S. Tagawa, B. Faltas, E. Lam, P. Saylor +10 more
2019Journal of Clinical Oncology80 citations
Semantic Scholar
Spinal Metastases 2021: A Review of the Current State of the Art and Future Directions.
D. Sciubba, Z. Pennington, M. Colman, C. R. Goodwin +7 more
2021The spine journal75 citations
Semantic Scholar
A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma
A. Alchahin, S. Mei, Ioanna Tsea, Taghreed Hirz +11 more
2022Nature Communications67 citations Open access
Semantic Scholar
Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions
Sheng-Lin Mei, A. Alchahin, Ioanna Tsea, Y. Kfoury +20 more
2024Genome Medicine51 citations Open access
Semantic Scholar
A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes
Carla Calagua, M. Ficial, Caroline S. Jansen, Taghreed Hirz +13 more
2021Clinical Cancer Research45 citations Open access
Semantic Scholar
Importance of fibroblast growth factor receptor in neovascularization and tumor escape from antiangiogenic therapy.
P. Saylor, B. Escudier, M. Michaelson
2012Clinical Genitourinary Cancer39 citations
Semantic Scholar
Whole exome sequencing of urachal adenocarcinoma reveals recurrent NF1 mutations
Harshabad Singh, Yang Liu, Xiu-Li Xiao, Ling Lin +5 more
2016OncoTarget35 citations Open access
Semantic Scholar
Single-cell and spatial transcriptomics reveal a tumor-associated macrophage subpopulation that mediates prostate cancer progression and metastasis
Sheng-Lin Mei, Han-Yu Zhang, Taghreed Hirz, N. Jeffries +8 more
2025Molecular Cancer Research34 citations
Semantic Scholar
Branched Chain RNA In Situ Hybridization for Androgen Receptor Splice Variant AR-V7 as a Prognostic Biomarker for Metastatic Castration-Sensitive Prostate Cancer
P. Saylor, Richard J. Lee, Kshitij S Arora, V. Deshpande +7 more
2016Clinical Cancer Research32 citations
Semantic Scholar
Metabolic complications of androgen deprivation therapy for prostate cancer.
P. Saylor, M. Smith
2013Journal of Urology31 citations Open access
Semantic Scholar
Prostate cancer: The androgen receptor remains front and centre
P. Saylor
2013Nature Reviews Clinical Oncology28 citations
Semantic Scholar
Single-cell analyses of metastatic bone marrow in human neuroblastoma reveals microenvironmental remodeling and metastatic signature
Sheng-Lin Mei, A. Alchahin, Bethel Tesfai Embaie, Ioana Maria Gavriliuc +16 more
2024JCI Insight27 citations Open access
Semantic Scholar
The effectiveness of systemic therapies after surgery for metastatic renal cell carcinoma to the spine: a propensity analysis controlling for sarcopenia, frailty, and nutrition.
E. Massaad, P. Saylor, Muhamed Hadzipasic, A. Kiapour +5 more
2021Journal of Neurosurgery : Spine21 citations Open access
Semantic Scholar
Predicting tumor-specific survival in patients with spinal metastatic renal cell carcinoma: which scoring system is most accurate?
E. Massaad, Muhamed Hadzipasic, Christopher A. Alvarez-Breckenridge, A. Kiapour +7 more
2020Journal of Neurosurgery : Spine21 citations Open access
Semantic Scholar
858PSacituzumab govitecan (IMMU-132) for patients with pretreated metastatic urothelial uancer (UC): interim results
S. Tagawa, B. Faltas, E. Lam, P. Saylor +13 more
201720 citations Open access
Semantic Scholar
Survival After Surgery for Renal Cell Carcinoma Metastatic to the Spine: Impact of Modern Systemic Therapies on Outcomes.
G. Shankar, Laura A. Van Beaver, Bryan D. Choi, Muhamed Hadzipasic +10 more
2020Neurosurgery18 citations Open access
Semantic Scholar
Bone-targeting radiopharmaceuticals for the treatment of bone-metastatic castration-resistant prostate cancer: exploring the implications of new data.
C. Ryan, P. Saylor, J. Everly, O. Sartor
2014The Oncologist16 citations Open access
Semantic Scholar
Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer
S. Kamran, Yu-Zheng Zhou, Keisuke Otani, Michael Drumm +18 more
2023Clinical Cancer Research13 citations Open access
Semantic Scholar
Bone targeted therapies for the prevention of skeletal morbidity in men with prostate cancer
P. Saylor
2014Asian Journal of Andrology12 citations Open access
Semantic Scholar
The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer
P. Saylor, S. V. Kozin, Aya Matsui, Saveli I. Goldberg +7 more
2024Radiotherapy and Oncology11 citations Open access
Semantic Scholar
Performance of 18F-fluciclovine PET/MR in the evaluation of osseous metastases from castration-resistant prostate cancer
B. Amorim, V. Prabhu, Sara Marcó, D. Gervais +5 more
2019European Journal of Nuclear Medicine and Molecular Imaging11 citations
Semantic Scholar
Long-Term Results of Bladder Preservation with Twice-Daily Radiation plus 5-Flourouracil/Cisplatin or Daily Radiation plus Gemcitabine for MIBC – Updated Report of NRG/RTOG 0712: A Randomized Phase 2 Trial
J. Coen, J. Rodgers, P. Saylor, Cheryl T. Lee +11 more
2024International Journal of Radiation Oncology, Biology, Physics10 citations
Semantic Scholar
Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
P. Saylor, Keisuke Otani, R. Balza, J. Ukleja +15 more
2024JCO Precision Oncology8 citations Open access
Semantic Scholar
CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 38-2015. A 21-Year-Old Man with Fatigue and Weight Loss.
J. C. Pallais, M. McInnis, P. Saylor, Roseann I. Wu
2015New England Journal of Medicine7 citations
Semantic Scholar
GnRH agonist-associated pituitary apoplexy: a case series and review of the literature
F. Guarda, Xiao-Ling Yu, Naila Shiraliyeva, Melanie S. Haines +3 more
2021Pituitary5 citations
Semantic Scholar
Therapy for chemopretreated metastatic urothelial cancer (mUC) with the antibody-drug conjugate (ADC) sacituzumab govitecan (IMMU-132).
S. Tagawa, A. Ocean, E. Lam, P. Saylor +13 more
20175 citations
Semantic Scholar
Impact of metastatic prostate cancer on human bone marrow
N. Baryawno, Y. Kfoury, N. Sévère, S. Mei +11 more
20204 citations
Semantic Scholar
Abstract CT064: Treatment for metastatic platinum-resistant urothelial cancer (PRUC) with an anti-Trop-2-SN-38 antibody-drug conjugate (ADC), sacituzumab govitecan (IMMU-132): phase I/II clinical experience
S. Tagawa, B. Faltas, E. Lam, W. Messersmith +12 more
20164 citations
Semantic Scholar
Investigator-sponsored trial of efficacy and tolerability of cabozantinib (cabo) at lower dose: A dose-finding study in men with castration-resistant prostate cancer (CRPC) and bone metastases.
Richard J. Lee, M. Michaelson, P. Saylor, Carol Gurski +6 more
20124 citations
Semantic Scholar
Clinical outcomes of de novo versus relapsed early metastatic testicular seminoma treated with contemporary radiation therapy.
D. B. Rosen, Anushka Ghosh, A. Niemierko, C. Beard +9 more
2023International Journal of Radiation Oncology, Biology, Physics3 citations
Semantic Scholar
A phase II study of onvansertib in combination with abiraterone and prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC).
David J. Einstein, A. Choudhury, P. Saylor, L. Werner +3 more
2019Journal of Clinical Oncology3 citations
Semantic Scholar
Androgen deprivation therapy for prostate cancer is associated in increased risk for biliary disease
P. Saylor, M. Smith, A. O'Malley, Nancy L. Keating
2013European Urology3 citations Open access
Semantic Scholar
Integrated single-cell and spatial transcriptomic analyses unravel the heterogeneity of the prostate tumor microenvironment
Taghreed Hirz, S. Mei, Hirak Sarkar, Y. Kfoury +16 more
2022bioRxiv2 citations Open access
Semantic Scholar
Informed Consent 2021: The "Terms and Conditions" of the Research World.
P. Saylor
2021The Oncologist2 citations Open access
Semantic Scholar
Bladder Preservation with Twice-Daily Radiation plus 5-Flourouracil/Cisplatin or Daily Radiation plus Gemcitabine for MIBC – Updated Results of NRG/RTOG 0712: A Randomized Phase 2 Trial
J. Coen, J. Rodgers, P. Saylor, Cheryl T. Lee +10 more
20202 citations
Semantic Scholar
Circulating Tumor Cells and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
H. Pleskow, K. Otani, E. Kusaka, J. Ukleja +7 more
20202 citations Open access
Semantic Scholar
Integrated Gene Expression Score in Circulating Tumor Cells to Predict Treatment Response in Muscle-Invasive Bladder Cancer
W. Hwang, H. Pleskow, J. A. Andrade Czapla, R. Fisher +10 more
2019International Journal of Radiation Oncology, Biology, Physics2 citations
Semantic Scholar
77. Development of predictive models for 90-day and 1-year mortality in spinal metastatic disease
A. Karhade, C. Bono, M. Ferrone, P. Saylor +4 more
2019The spine journal2 citations
Semantic Scholar
Selective Bladder Preservation with Twice-Daily Radiation Plus 5-Flourouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Patients with Muscle Invasive Bladder Cancer—Primary Results of NRG/RTOG 0712: A Randomized Phase 2 Multicenter Trial
J. Coen, Peixin Zhang, P. Saylor, Cheryl T. Lee +11 more
20172 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

John H. Shin×10
Invite
John H. Shin — researcher profile on SciRah
J. Efstathiou×9
Invite
J. Efstathiou — researcher profile on SciRah
Taghreed Hirz×8
Invite
Taghreed Hirz — researcher profile on SciRah
Chin-Lee Wu×8
Invite
Chin-Lee Wu — researcher profile on SciRah

×8

Invite

N. Baryawno — researcher profile on SciRah

Invite

A. Zietman — researcher profile on SciRah

Invite

D. Miyamoto — researcher profile on SciRah

Andrew J. Schoenfeld×7

Invite

Andrew J. Schoenfeld — researcher profile on SciRah

Invite

J. Schwab — researcher profile on SciRah

Invite

D. Dahl — researcher profile on SciRah

Invite

Y. Kfoury — researcher profile on SciRah

Invite

D. Sykes — researcher profile on SciRah